AzTrials
AzTrials

Cancer SurvivorshipNCT07528963

KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice

A study testing KanSurvive telementoring and education, Practice facilitation for quality improvement and Obesity management toolkit in people with Cancer Survivorship and Primary Care, run by University of Kansas Medical Center at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Rural cancer survivors experience a higher risk of negative health outcomes and require coordinated care to address the many effects of cancer and its treatment. Primary care providers recognize the importance of providing high-quality, evidence-based survivorship care and are well-positioned to meet survivor needs… Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Cancer Survivorship, Primary Care
What is being tested?
KanSurvive telementoring and education, Practice facilitation for quality improvement and Obesity management toolkit
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
16 participants
Where
1 siteUnited States
Study dates
30 Jun 2025to 30 Jun 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Rural primary care practice (PCP) located within rural urban continuum codes (RUCC) 4-9 in Kansas
  • PCPs must have multiple providers
  • PCPs must have at least on medical assistant
  • PCPs must have an employed medical scribe or be willing to consider employing a medical scribe using study compensation and practice revenue
  • Cancer survivor data is eligible for extraction if the patient is a breast, prostate, lung, and/or colorectal cancer survivor and considered to have a "reasonable likelihood" of 24-month survival by a practice provider.

Who cannot join

  • PCPs not located within RUCC 4-9 in Kansas
  • PCPs without multiple providers
  • PCPs without a medical assistant
  • PCPs without a medical scribe or unwilling to consider employing one
  • Cancer survivorship data is ineligible for extraction is the patient is <18 years of age or >75 years of age, is currently receiving hospice services, or has a history of cancer other than breast, prostate, lung, or colorectal.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

Other trials in United States

About this study

Rural cancer survivors experience a higher risk of negative health outcomes and require coordinated care to address the many effects of cancer and its treatment. Primary care providers recognize the importance of providing high-quality, evidence-based survivorship care and are well-positioned to meet survivor needs, however, these needs are often unmet due to limitations in knowledge, lack of resources, and administrative demands. Practical strategies are needed to help PCPs improve cancer survivorship care, and this proposal will test implementation strategies to optimize the adoption of evidence-based practices for cancer survivorship care in rural primary care settings.

Read the detailed description

Cancer survivors require long-term and coordinated care to address the physical, emotional, and psychosocial effects of cancer and its treatment. Rural cancer survivors are disproportionately affected by chronic illness and face a higher risk of negative health outcomes. Primary care providers (PCPs) recognize the importance of delivering evidence-based practice (EBP) cancer survivorship care and are well-positioned to provide comprehensive and coordinated care, however, the needs of cancer survivors are frequently unmet, and providers describe limitations in knowledge of risk-based surveillance, long-term effects of cancer treatment and their management, inadequate resources, and growing administrative demands as barriers to improving survivorship care. The overall goal of this project is to test the effectiveness of pragmatic strategies to promote high quality, evidence-based guideline concordant care for rural adult cancer survivors in primary care practice and utilizing tools from implementation science to gain a better understanding of the decision making and actions taken that facilitate or hinder implementation across multiple healthcare systems. To achieve this objective, we propose a three-arm cluster-randomized, multi-level intervention to provide education, tele-mentoring, and whether 1) virtual scribes filling the role as trained medical assistants, 2) a team-based approach, 3) or usual care produces more guideline concordant cancer survivorship care. The primary outcome is provider adherence to EBP cancer survivorship guidelines as measured using a previously developed composite scoring system that compares electronic health record (EHR) documented activity to National Comprehensive Cancer Network guidelines. The secondary outcome is to assess intervention sustainability of arm 1 and 2 activities at 12 and 24-months post implementation; measured as a function of virtual scribe or team-based actions to promote prior cancer diagnoses coding (ICD-10), use of EHR tools and health maintenance order sets and annual ordering of appropriate screenings for cancer survivors. Prior to implementation, formative evaluations will assess current systems of care and practice-level barriers and facilitators for the delivery of EBP cancer survivorship care and inform modifications to implementation strategies. Guided by the Normalization Process Theory, we will examine agentic factors (e.g., actions taken/decisions made by the practice) to modify modes of care management and delivery. The RE-AIM evaluation framework will be used to explore potential population-level impact and generalizability of the intervention in real-world clinical settings. The study will be conducted in 16 rural primary care practices in Kansas and was intentionally designed to bring care delivery changes into resource-limited practices and health systems. Results will add new evidence by informing pragmatic strategies to facilitate the adoption and delivery of EBP cancer survivorship in rural primary care.

Being tested
KanSurvive telementoring and education, Practice facilitation for quality improvement, Obesity management toolkit, Survivorship Care Manual, Virtual scribe services
Keywords
cancer survivorship, primary care practice

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KanSurvive telementoring and educationOther

    Telementoring, education, and case-based learning covering evidence-based practice guidelines for breast, colorectal, lung, and prostate cancer survivorship.

  • Practice facilitation for quality improvementOther

    Practice facilitation will be delivered to assist with quality improvement efforts using monthly Plan Do Study Act (PDSA) cycles.

  • Obesity management toolkitOther

    The Enhanced Usual Care arm will receive a short, virtual training and toolkit on the management of obesity in primary care practice and how it relates to cancer survivorship.

  • Survivorship Care ManualOther

    Printed and digital manuals will be distributed to each participating primary care practice to share with the cancer survivors they see in their clinic. The manual guides patients on how to engage more effectively with their PCP and oncology care team and reviews recommended follow-up, within a format of a "service manual" and written in lay language.

  • Virtual scribe servicesOther

    Participating practices who opt-in to receive virtual scribe services.

Study groups in NCT07528963
Study groupRoleWhat they receive
Virtual Scribe Medical AssistantActive comparatorVirtual scribe medical assistants will engage in KanSurvive 2.0 Project ECHO education assist with clinical documentation, identifying cancer survivors, and scrubbing electronic health records to identify care gaps and opportunities for quality improvement with practice facilitation.
Receives: Other: KanSurvive telementoring and education; Other: Practice facilitation for quality improvement; Other: Survivorship Care Manual; Other: Virtual scribe services
Team Based CareActive comparatorRural primary care practice teams will assist with clinical documentation, identifying cancer survivors, and reviewing electronic health records to identify care gaps and opportunities for quality improvement with practice facilitation.
Receives: Other: KanSurvive telementoring and education; Other: Practice facilitation for quality improvement; Other: Survivorship Care Manual
Enhanced Usual CarePlacebo comparatorThis attention control arm will engage in KanSurvive 2.0 Project ECHO education and receive an obesity management toolkit.
Receives: Other: KanSurvive telementoring and education; Other: Obesity management toolkit; Other: Survivorship Care Manual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Provider Adherence to Cancer Survivorship Guidelines Measured by EHR-Based Composite Adherence Score

    The primary outcome is provider adherence to evidence-based cancer survivorship guidelines, measured using a composite score derived from electronic health record (EHR) data abstraction. The composite score assesses concordance between documented care and National Comprehensive Cancer Network (NCCN) survivorship guidelines across multiple domains (e.g., tumor surveillance, distress screening, BMI assessment, tobacco use screening, family history of cancer documentation, osteoporosis screening, and hereditary cancer risk assessment). Scores are calculated based on the proportion of eligible guideline-concordant care processes completed for each patient and aggregated at the clinic level.

    Measured: Assessed at baseline, 6, 12, and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2026
  2. Study start30 Jun 2025
  3. Primary completion1 Aug 2028 (estimated)
  4. Study completion30 Jun 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
8 rural primary care practices will be randomized to the Virtual Scribe Medical Assistant arm, 4 rural primary care practices will be randomized to the Team-Based Care arm, and 4 rural primary care practices will be randomized to the Enhanced Usual Care control arm.
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07528963
Sponsor's protocol ID
STUDY00160108
Other IDs
U01CA290664
Status last verified
Jun 2026
First submitted
15 Apr 2025
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Research resources generated within this project will be explicitly developed in an effort to improve cancer survivorship outcomes in rural primary care practice. We will develop a strategic plan with the KU Cancer Center and NCI to widely disseminate any product, intellectual property, or data to promote scientific activity and health promotion work that will be of assistance to similar patient populations. As such, we will work to fully share these materials and items with qualified individuals across the greater scientific community and with rural practices, providers and community members. All program materials and data generated within the overall study will be shared to the fullest extent possible. De-identified data from this project will be preserved and shared in a public repository to validate and replicate research findings described in the Aims.

Questions about this trial

What is this clinical trial studying?

A study testing KanSurvive telementoring and education, Practice facilitation for quality improvement and Obesity management toolkit in people with Cancer Survivorship and Primary Care, run by University of Kansas Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Provider Adherence to Cancer Survivorship Guidelines Measured by EHR-Based Composite Adherence Score (time frame: Assessed at baseline, 6, 12, and 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in